People News

Progenics Pharmaceuticals promoted Mark Baker to the newly created position of president. Baker will continue to report to Paul Maddon, the company's founder. Baker will be responsible for overseeing the company's commercial development, strategic planning, business development, communications, finance and accounting, operations and legal affairs, according to a company statement. He was also promoted to Progenics' board of directors.

Swiss specialty pharma Addex Pharmaceuticals' head of business development Laurent Massuyeau has resigned, the company announced, without further explanation. He was also a member of the executive management team.


You must be a registered member of MMM to post a comment.
close

Next Article in Channel

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.